Rubicon Healthcare Partners
Overview
Rubicon Healthcare Partners is a Nordic growth equity investment firm that invests in growth-stage companies that enable and drive innovation across the life science industry, with a focus on manufacturing technologies, outsourced services, and advanced research tools.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PeptiSystems AB | Nov 2025 | Growth Equity | Lead |
| Moleculent | Apr 2026 | Series A Extension | Lead |
Key People
Sebastian Intveen
Managing Partner
Espen Basmo Ellingsen
Partner
Øystein Åmellem
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Rubicon Healthcare Partners based?
Rubicon Healthcare Partners is headquartered in Norway.
When was Rubicon Healthcare Partners founded?
Rubicon Healthcare Partners was founded in 2024.
How many portfolio companies does Rubicon Healthcare Partners have?
Rubicon Healthcare Partners has 2 portfolio companies in Caplight's dataset.
What are some companies in Rubicon Healthcare Partners's portfolio?
Portfolio companies visible on Caplight include PeptiSystems AB, Moleculent.
What was Rubicon Healthcare Partners's most recent investment shown here?
Rubicon Healthcare Partners's most recent investment in this portfolio sample was in Moleculent in 2026.
What sectors does Rubicon Healthcare Partners focus on?
Rubicon Healthcare Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Rubicon Healthcare Partners focus on?
Rubicon Healthcare Partners typically invests at the Early stage.